マルタ - 英語 - Medicines Authority

medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - amoxicillin, clavulanic acid - powder for oral suspension - clavulanic acid 62.5 mg/5ml amoxicillin 250 mg/5ml - antibacterials for systemic use

マルタ - 英語 - Medicines Authority

medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - amoxicillin, clavulanic acid - film-coated tablet - amoxicillin 875 mg clavulanic acid 125 mg - antibacterials for systemic use

マルタ - 英語 - Medicines Authority

medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - clavulanic acid, amoxicillin sodium - powder for solution for infusion or injection - amoxicillin sodium 1000 mg clavulanic acid 200 mg - antibacterials for systemic use

欧州連合 - 英語 - EMA (European Medicines Agency)

hexal ag - filgrastim - neutropenia; hematopoietic stem cell transplantation; cancer - immunostimulants, - reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes) and reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone-marrow transplantation considered to be at increased risk of prolonged severe neutropenia.the safety and efficacy of filgrastim are similar in adults and children receiving cytotoxic chemotherapy.mobilisation of peripheral blood progenitor cells (pbpcs).in children and adults with severe congenital, cyclic, or idiopathic neutropenia with an absolute neutrophil count (anc) of of ≤ 0.5 x 109/l, and a history of severe or recurrent infections, long-term administration of filgrastim is indicated to increase neutrophil counts and to reduce the incidence and duration of infection-related events.treatment of persistent neutropenia (anc ≤ 0.5 x 109/l), and a history of severe or recurrent infections, long-term administration of filgrastim is indicated to increase neutrophil counts and to reduce the incidence and duration of infection-related events.in patients with advanced hiv infection, in order to reduce the risk of bacterial infections when other therapeutic options are inappropriate.

欧州連合 - 英語 - EMA (European Medicines Agency)

sandoz gmbh - filgrastim - neutropenia; hematopoietic stem cell transplantation; cancer - immunostimulants, - reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes) and reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone-marrow transplantation considered to be at increased risk of prolonged severe neutropenia. the safety and efficacy of filgrastim are similar in adults and children receiving cytotoxic chemotherapy.mobilisation of peripheral blood progenitor cells (pbpc).in children and adults with severe congenital, cyclic, or idiopathic neutropenia with an absolute neutrophil count (anc) of ≤0.5 x 109/l, and a history of severe or recurrent infections, long term administration of filgrastim is indicated to increase neutrophil counts and to reduce the incidence and duration of infection-related events.treatment of persistent neutropenia (anc ≤ 1.0 x 109/l) in patients with advanced hiv infection, in order to reduce the risk of bacterial infections when other therapeutic options are inappropriate.

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

tillomed laboratories ltd - carvedilol - oral tablet - 3.125mg

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

tillomed laboratories ltd - cefuroxime axetil - oral tablet - 250mg

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

bristol laboratories ltd - ondansetron hydrochloride dihydrate - oral tablet - 4mg

マルタ - 英語 - Medicines Authority

medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - amoxicillin, clavulanic acid - powder for oral suspension - amoxicillin 400 mg/5ml clavulanic acid 57 mg/5ml - antibacterials for systemic use

アルメニア - 英語 - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

medochemie ltd- factory b - amoxicillin (amoxicillin trihydrate), clavulanic acid (potassium clavulanate) - tablets film-coated - 875mg+ 125mg (14/2x7/) in blister